Agomab Therapeutics Nv's ROA from the fourth quarter of 2025 to the fourth quarter of and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Agomab Therapeutics Nv's ROA in the fourth quarter of 2025?
Agomab Therapeutics Nv recorded a cumulative net loss of $-70 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -40.69%.

However, within the Healthcare sector Agomab Therapeutics Nv achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the third quarter of 2025 at no. .

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter
Y / Y Total Assets Change	-	-	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-70	0	0	0	0
Return On Assets (TTM)	-40.69 %	0 %	0 %	0 %	-
AGMB's Total Ranking	#	#	#	#	#
Total Assets (TTM) in million	172	172	172	172	0
Seq. Total Assets Change	0 %	0 %	0 %	-	-
Seq. Net Income Change	-	-	-	-	-

AGMB's 5 Years Annual ROA >> Back to AGMB Management Effectiveness >> Compare AGMB ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Assets Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Agomab Therapeutics Nv's Assets	$ 172 million	AGMB's Balance sheet
Agomab Therapeutics Nv's Income	$ -70 million	Quarterly AGMB's Income Statement
AGMB's Income by Division		See AGMB's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	FY	FY	FY	FY
Y / Y Total Assets Change	-	-	-	-	-
Total Assets in million	172	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-70	0	0	0	0
Annual Return On Assets	-40.69 %	-	-	-	-

AGMB's 5 Years Annual ROA >> Back to AGMB Management Effectiveness >> Compare AGMB ROA to its Competitors

More Return On Assets Ratios
AGMB's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
AGMB's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for AGMB's Competitors
Subscribers only: Roa for Agomab Therapeutics Nv's Suppliers
Subscribers only: Return On Assets for AGMB's Customers

You may also want to know
AGMB's Roi	AGMB's Inventory Turnover Ratio	AGMB's Growth Rates	AGMB's Dividend Comparisons
	AGMB's Profitability Ratios	AGMB's Asset Turnover Ratio	AGMB's Dividend Growth
AGMB's Roe	AGMB's Valuation Ratios	AGMB's Financial Strength Ratios	AGMB's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector

ROA

Date modified: 2026-04-24T15:30:01+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.